Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

STVN

Stevanato (STVN)

Stevanato Group SpA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:STVN
DatumZeitQuelleÜberschriftSymbolFirma
31/05/202422h30Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:STVNStevanato Group SpA
30/05/202411h00Business WireStevanato Group Unveils New Plant in Cisterna di Latina for the Production of Pre-Sterilized EZ-fill® Syringes and CartridgesNYSE:STVNStevanato Group SpA
28/05/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
28/05/202413h00Business WireStevanato Group Appoints Franco Stevanato Chief Executive Officer, Succeeding Franco MoroNYSE:STVNStevanato Group SpA
24/05/202422h51Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
24/05/202422h10Business WireStevanato Group Announces Results of Annual General MeetingNYSE:STVNStevanato Group SpA
23/05/202422h30Business WireStevanato Group to Present at Upcoming Investor ConferencesNYSE:STVNStevanato Group SpA
20/05/202422h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:STVNStevanato Group SpA
16/05/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
14/05/202422h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
09/05/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
09/05/202412h39Business WireStevanato Group Reports Financial Results for the First Quarter of 2024NYSE:STVNStevanato Group SpA
01/05/202422h30Business WireStevanato Group to Present at the Bank of America Securities Healthcare ConferenceNYSE:STVNStevanato Group SpA
25/04/202422h04Business WireStevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024NYSE:STVNStevanato Group SpA
04/04/202414h00Business WireStevanato Group appoints Ugo Gay as Chief Operations OfficerNYSE:STVNStevanato Group SpA
26/03/202421h10Business WireStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesNYSE:STVNStevanato Group SpA
22/03/202404h45Business WireStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
20/03/202422h12Business WireStevanato Group Announces Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
11/03/202422h05Business WireStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNYSE:STVNStevanato Group SpA
07/03/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
07/03/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
07/03/202412h30Business WireStevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023NYSE:STVNStevanato Group SpA
22/02/202422h30Business WireStevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024NYSE:STVNStevanato Group SpA
24/01/202414h00Business WireStevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationNYSE:STVNStevanato Group SpA
03/01/202422h30Business WireStevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:STVNStevanato Group SpA
16/11/202312h00Business WireStevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingNYSE:STVNStevanato Group SpA
09/11/202322h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
09/11/202312h30Business WireStevanato Group to Present at the Jefferies London Healthcare ConferenceNYSE:STVNStevanato Group SpA
03/11/202321h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
31/10/202316h58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
 Showing the most relevant articles for your search:NYSE:STVN